Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Fibrobiologics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
FBLG
Nasdaq
8731
https://fibrobiologics.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Fibrobiologics Inc
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids
- Apr 25th, 2024 12:00 pm
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office
- Apr 11th, 2024 1:31 pm
FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA
- Apr 4th, 2024 1:31 pm
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
- Mar 28th, 2024 1:31 pm
FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment
- Mar 19th, 2024 1:31 pm
FibroBiologics to Present at Advanced Wound Care Summit USA
- Mar 13th, 2024 1:31 pm
FibroBiologics Appoints Ruben A. Garcia as General Counsel
- Mar 6th, 2024 2:31 pm
FibroBiologics Files 2023 Form 10-K Annual Report
- Feb 29th, 2024 10:44 pm
FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum
- Feb 20th, 2024 2:31 pm
FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases
- Feb 13th, 2024 2:31 pm
FibroBiologics Announces Three United States Patents for Fibroblast Technology
- Feb 8th, 2024 2:31 pm
FibroBiologics Announces Three Japanese Patents on Fibroblast Technology
- Feb 6th, 2024 2:31 pm
FibroBiologics Announces Direct Listing on NASDAQ Under the Stock Ticker FBLG
- Jan 31st, 2024 3:00 pm
Scroll